Mitochondrial Etiology of Neuropsychiatric Disorders

被引:126
作者
Pei, Liming
Wallace, Douglas C. [1 ]
机构
[1] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Colket Translat Res Bldg,6th Floor, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; Autism; Mitochondria; mtDNA; Nuclear receptors; OXPHOS; HEREDITARY OPTIC NEUROPATHY; AUTISM SPECTRUM DISORDER; BIPOLAR AFFECTIVE-DISORDER; SUBSTANTIA-NIGRA NEURONS; DNA DELETION LEVELS; ERR-GAMMA; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; PARKINSON-DISEASE; RECEPTOR-ALPHA;
D O I
10.1016/j.biopsych.2017.11.018
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The brain has the highest mitochondrial energy demand of any organ. Therefore, subtle changes in mitochondrial energy production will preferentially affect the brain. Considerable biochemical evidence has accumulated revealing mitochondrial defects associated with neuropsychiatric diseases. Moreover, the mitochondrial genome encompasses over a thousand nuclear DNA genes plus hundreds to thousands of copies of the maternally inherited mitochondrial DNA (mtDNA). Therefore, partial defects in either the nuclear DNA or mtDNA genes or combinations of the two can be sufficient to cause neuropsychiatric disorders. Inherited and acquired mtDNA mutations have recently been associated with autism spectrum disorder, which parallels previous evidence of mtDNA variation in other neurological diseases. Therefore, mitochondrial dysfunction may be central to the etiology of a wide spectrum of neurological diseases. The mitochondria and the nucleus communicate to coordinate energy production and utilization, providing the potential for therapeutics by manipulating nuclear regulation of mitochondrial gene expression.
引用
收藏
页码:722 / 730
页数:9
相关论文
共 50 条
  • [21] Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders
    Giri, Aditi
    Mehan, Sidharth
    Khan, Zuber
    Das Gupta, Ghanshyam
    Narula, Acharan S.
    Kalfin, Reni
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (06) : 3867 - 3895
  • [22] Editorial: Glutamate-Related Biomarkers for Neuropsychiatric Disorders
    Lin, Chieh-Hsin
    Hashimoto, Kenji
    Lane, Hsien-Yuan
    FRONTIERS IN PSYCHIATRY, 2019, 10
  • [23] Brain Insulin Dysregulation: Implication for Neurological and Neuropsychiatric Disorders
    Ghasemi, Rasoul
    Dargahi, Leila
    Haeri, Ali
    Moosavi, Maryam
    Mohamed, Zahurin
    Ahmadiani, Abolhassan
    MOLECULAR NEUROBIOLOGY, 2013, 47 (03) : 1045 - 1065
  • [24] Brain Insulin Dysregulation: Implication for Neurological and Neuropsychiatric Disorders
    Rasoul Ghasemi
    Leila Dargahi
    Ali Haeri
    Maryam Moosavi
    Zahurin Mohamed
    Abolhassan Ahmadiani
    Molecular Neurobiology, 2013, 47 : 1045 - 1065
  • [25] Synapse-to-Nucleus Signaling in Neurodegenerative and Neuropsychiatric Disorders
    Parra-Damas, Arnaldo
    Saura, Carlos A.
    BIOLOGICAL PSYCHIATRY, 2019, 86 (02) : 87 - 96
  • [26] Meta-analyses of RELN variants in neuropsychiatric disorders
    Chen, Na
    Bao, Yanping
    Xue, Yanxue
    Sun, Yan
    Hu, Die
    Meng, Shiqiu
    Lu, Lin
    Shi, Jie
    BEHAVIOURAL BRAIN RESEARCH, 2017, 332 : 110 - 119
  • [27] Omega-3 fatty acids and neuropsychiatric disorders
    Young, G
    Conquer, J
    REPRODUCTION NUTRITION DEVELOPMENT, 2005, 45 (01): : 1 - 28
  • [28] A Perspective on the Potential Involvement of Impaired Proteostasis in Neuropsychiatric Disorders
    Hui, Kelvin K.
    Endo, Ryo
    Sawa, Akira
    Tanaka, Motomasa
    BIOLOGICAL PSYCHIATRY, 2022, 91 (04) : 335 - 345
  • [29] The Histaminergic System in Neuropsychiatric Disorders
    Cheng, Li
    Liu, Jiaying
    Chen, Zhong
    BIOMOLECULES, 2021, 11 (09)
  • [30] Toxoplasmosis: A pathway to neuropsychiatric disorders
    Tyebji, Shiraz
    Seizova, Simona
    Hannan, Anthony J.
    Tonkin, Christopher J.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2019, 96 : 72 - 92